poisar

Stocks · News reference

Cigna Expects Lower Growth in Popular GLP-1 Drug Prescriptions

BenzingaJul 30, 2026, 6:15 PMVandana Singh

Cigna beat second-quarter earnings and revenue estimates, raised its 2026 profit outlook and said GLP-1 utilization growth is moderating.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Jul 30, 2026, 6:15 PM
Checked
Jul 30, 2026, 6:14 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Zacks Investment ResearchAug 27, 2026, 2:20 PMNa

    Can Cigna's Smart Coverage Help Close Health-Cost Gaps?

    Cigna Healthcare is introducing Smart Coverage, a new benefit option that automatically links medical claims with supplemental benefits to provide eligible members up to $7,000 for covered health events. The program launches January 1, 2027, for mid-sized employers and addresses a significant affordability gap, with nearly 60% of Americans unprepared for health costs. The initiative is designed to increase enrollment in high-deductible plans and boost supplemental product participation.

    Read original at zacks-investment-research